U.S. Cell Culture Media Market Size & Outlook, 2023-2030
U.S. cell culture media market, 2018-2030 (US$M)
Related Markets
U.S. cell culture media market highlights
- The U.S. cell culture media market generated a revenue of USD 1,468.8 million in 2023 and is expected to reach USD 3,040.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11% from 2024 to 2030.
- In terms of segment, serum-free media was the largest revenue generating product in 2023.
- Serum-free Media is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture media market data book summary
| Market revenue in 2023 | USD 1,468.8 million |
| Market revenue in 2030 | USD 3,040.4 million |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Serum-free media |
| Fastest growing segment | Serum-free Media |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.1% of the global cell culture media market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cell culture media market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 698.0 million by 2030.
Serum-free media was the largest segment with a revenue share of 37.19% in 2023. Horizon Databook has segmented the U.S. cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
Biotechnology industry regulations in the U.S. are governed by Coordinated Framework for Regulation of Biotechnology established in 1986. This framework outlines the federal policy for regulating products developed with the help of modern biotechnology. The country has three main Federal agencies—the Animal and Plant Health Inspection Service (APHIS), the U.S. Environmental Protection Agency (EPA), and the U.S.
Department of Health and Human Services’ Food and Drug Administration (FDA)—which ensure safe use of genetically modified/engineered organisms. In particular, the U.S. FDA is primarily responsible for ensuring safety, efficacy, proper labeling, and other attributes of human food, animal feed, and all plant-derived foods & feeds.
The EPA dictates regulations for pesticides, including plant-incorporated protectants, to ensure public safety. It also regulates the extent of pesticide residue present in food and feed. In addition, the APHIS hosts a Biotechnology Regulatory Services program that stipulates regulations regarding the use of genetically engineered organisms that may pose a risk to plant health.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Media Market Scope
Cell Culture Media Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. cell culture media market size, by product, 2018-2030 (US$M)
U.S. Cell Culture Media Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
